Azurity Pharmaceuticals growth playbook

Replace the title and structured-data description with approved, current wording (for example the existing meta description's "only FDA-approved oral liquid alternative to solid zonisamide doses" line, plus "available at pharmacies"). Then audit every CNS brand site the same day for launch-era wording: titles, descriptions, "coming soon" banners, social preview images and the pharmacist section. Add a check of titles and descriptions to each brand's quarterly review.

The search result is the first thing a prescriber or pharmacist sees, and "Available Soon" reads as "not stocked". Fixing it is a one-line, MLR-reviewable change on a mature brand that the new director inherits on day one.

[ ] Page title and meta description current
[ ] Structured-data name and description current
[ ] No "coming soon" or "available soon" banners
[ ] Social preview title, description and image set
[ ] Pharmacist section lists how to order
[ ] Prescribing information link works
[ ] Last reviewed date recorded

• Wording outside approved claims

  Use only text already approved for the brand site.

• Old snippet lingers in search

  Request recrawl and check again after two weeks.

• Brand websitezonisade.com, checked twice on October 23, 2026: the page title served to browsers and search engines reads "ZONISADE® (zonisamide oral suspension | Zonisamide Transformed | Now Approved - Available Soon!", and the site's structured data gives the description "Now Approved - Available Soon!". The meta description says ZONISADE is "the only FDA-approved oral liquid alternative to solid zonisamide doses". The site has "Provider Resources", "Request Information" and "Just For Pharmacists" sections.Source
• News coverageZonisade was approved in July 2022 and reached U.S. retail pharmacies from October 17, 2022, as adjunctive therapy for partial-onset seizures in adults and patients 16 and older; it was described as the first and only FDA-approved oral liquid formulation of zonisamide.Source
• HiringDirector, Brand Marketing - CNS (Woburn, MA or Raleigh, NC; posted October 22, 2026): drive "North America brand strategy, in-line marketing execution, and launch planning for both current and future brand assets"; "Monitor brand performance, KPIs, and market dynamics"; oversee products "at various lifecycle stages (pre-launch, launch, growth, maturity)"; and work with sales training on "commercial training for the franchise".Source
• Brand websitesThe HTML served by arynta.com, lamlique.com, eprontia.com and javadin.com has no page title, no meta description and no social preview tags; katerzia.com and danziten.com send only the brand name as the title. The pages fill in only after scripts run. zonisade.com, on WordPress, does send a full title and description.Source

Set a title, meta description and Open Graph/Twitter tags for each page and news record in Experience Cloud's SEO settings (or a head-markup component), using the release headline and summary for news. Enable server-side rendering or prerendering for public pages if the platform allows it. Test with a plain HTTP fetch and a LinkedIn post preview.

Every launch release and executive announcement is shared as a link; a clear title and summary decide whether investors, partners and press open it.

• Platform limits on head tags

  Use the platform's SEO fields or a prerender service.

• Your websiteazurity.com runs on Salesforce Experience Cloud. The HTML the server sends for the homepage, the products A-Z page, the HCP support page and news releases (checked October 23, 2026) has the same title, "Welcome to LWC Communities!", with no meta description, no Open Graph or social preview tags and no page text; content appears only after scripts run. The sitemap lists 102 URLs: 43 pages, 37 news releases and 22 leadership profiles, all re-dated September 2026.Source
• HiringSenior CRM Business Analyst (posted September 10, 2026): "Our CX team at Azurity is building new capabilities utilizing cutting-edge AI and Engagement tools"; configures Salesforce Sales Cloud including "Territory Planning, Flow Automation, Events, Consent Management, Reporting, Dashboards, and CRM Analytics", with IQVIA and Snowflake data, under "HIPAA, GDPR, Sunshine Act, FDA guidance".Source
• Your websiteSitemap pages for healthcare professionals and partners: products A-Z, HCP support, patient access support, medical information, educational grant application, "partner with Azurity" and "Azurity's legacy companies"; the newsroom includes releases on Arbor, Covis, Slayback and Sebela deals and licensing deals with George Medicines and ACA Pharma.Source

Export the old release URLs from search results, analytics and backlink tools, match each to its new page by headline, and add 301 redirects. Redirect retired product pages to the products A-Z page.

Links from trade press and partners carry authority and readers; redirects keep both.

• Some releases were not migrated

  Redirect to the newsroom and republish if needed.

• Your websiteOlder press release addresses that search engines still return, such as azurity.com/azurity-pharmaceuticals-announces-arynta-lisdexamfetamine-dimesylate-oral-solution-cii/ (February 2026) and the Covis acquisition release, return 404 Not Found without a redirect (checked twice on October 23, 2026). The same releases now live at new addresses under /news/<record id>/<slug>.Source
• Your websiteazurity.com runs on Salesforce Experience Cloud. The HTML the server sends for the homepage, the products A-Z page, the HCP support page and news releases (checked October 23, 2026) has the same title, "Welcome to LWC Communities!", with no meta description, no Open Graph or social preview tags and no page text; content appears only after scripts run. The sitemap lists 102 URLs: 43 pages, 37 news releases and 22 leadership profiles, all re-dated September 2026.Source
• Your websiteSitemap pages for healthcare professionals and partners: products A-Z, HCP support, patient access support, medical information, educational grant application, "partner with Azurity" and "Azurity's legacy companies"; the newsroom includes releases on Arbor, Covis, Slayback and Sebela deals and licensing deals with George Medicines and ACA Pharma.Source

Add an approved title, description and preview image to each brand site's served HTML, with the brand name, generic name and form ("oral suspension", "oral solution"). Check each in search and in a link preview.

Launch weeks are when brand names are searched and shared most.

• Review delays

  Submit all sites as one review packet.

• Brand websitesThe HTML served by arynta.com, lamlique.com, eprontia.com and javadin.com has no page title, no meta description and no social preview tags; katerzia.com and danziten.com send only the brand name as the title. The pages fill in only after scripts run. zonisade.com, on WordPress, does send a full title and description.Source
• News coverageLamlique (lamotrigine) oral suspension was approved in late September 2026: a ready-to-use oral liquid that "does not require compounding or refrigeration", in 5 mg/mL and 25 mg/mL strengths, for epilepsy in patients 2 and older and bipolar I maintenance in adults, with a Boxed Warning for serious skin rashes.Source
• News coverageArynta (lisdexamfetamine dimesylate) oral solution, the first approved oral solution of lisdexamfetamine, became available in the U.S. in April 2026 (earlier than the mid-2026 timing announced in February) for ADHD in patients 6 and older; Adalvo is a commercial partner.Source
• HiringDirector, Brand Marketing - CNS (Woburn, MA or Raleigh, NC; posted October 22, 2026): drive "North America brand strategy, in-line marketing execution, and launch planning for both current and future brand assets"; "Monitor brand performance, KPIs, and market dynamics"; oversee products "at various lifecycle stages (pre-launch, launch, growth, maturity)"; and work with sales training on "commercial training for the franchise".Source

Add therapeutic-area and type tags (approval, availability, deal), filter buttons, and an email or RSS alert for each tag.

Easier following means more pickup for each launch release.

• Low sign-ups

  Offer alerts on every release page.

• Your websiteazurity.com runs on Salesforce Experience Cloud. The HTML the server sends for the homepage, the products A-Z page, the HCP support page and news releases (checked October 23, 2026) has the same title, "Welcome to LWC Communities!", with no meta description, no Open Graph or social preview tags and no page text; content appears only after scripts run. The sitemap lists 102 URLs: 43 pages, 37 news releases and 22 leadership profiles, all re-dated September 2026.Source
• Your websiteSitemap pages for healthcare professionals and partners: products A-Z, HCP support, patient access support, medical information, educational grant application, "partner with Azurity" and "Azurity's legacy companies"; the newsroom includes releases on Arbor, Covis, Slayback and Sebela deals and licensing deals with George Medicines and ACA Pharma.Source
• News coverageAzurity operates in more than 50 countries with a portfolio of more than 50 medicines across therapeutic areas and dosage forms (after the Covis acquisition); in March 2026 its owner QHP Capital closed a $1.1 billion continuation vehicle to fund organic growth, business development and licensing, and M&A.Source

Add filters to products A-Z for dosage form (oral liquid, injectable, tablet), setting (hospital, retail, specialty) and therapeutic area, each linking to prescribing information and ordering details. Give reps a printable version.

Pharmacists look for a form that fits a patient who cannot swallow or a hospital workflow; a finder answers that in seconds.

• Seen as promotional

  Keep to labeled facts and PI links.

• HiringField expansion: Institutional Business Managers in at least nine territories (Central Valley, Columbus, Connecticut, Detroit, North Los Angeles, Phoenix South, Portland, Sacramento, South Atlanta), Hospital & Specialty Sales Representatives (San Jose, West Chicago) and a Regional Business Manager, Midwest, posted August to October 2026. Call points include "Hospital Pharmacy, OR, ICU"; preferred experience includes "Buy and Bill & Injectable product", oncology and "familiarity with P&T/Formulary process".Source
• News coverageAzurity operates in more than 50 countries with a portfolio of more than 50 medicines across therapeutic areas and dosage forms (after the Covis acquisition); in March 2026 its owner QHP Capital closed a $1.1 billion continuation vehicle to fund organic growth, business development and licensing, and M&A.Source
• Your websiteSitemap pages for healthcare professionals and partners: products A-Z, HCP support, patient access support, medical information, educational grant application, "partner with Azurity" and "Azurity's legacy companies"; the newsroom includes releases on Arbor, Covis, Slayback and Sebela deals and licensing deals with George Medicines and ACA Pharma.Source

Write down the Lamlique launch as a template: site checklist, pharmacist stocking communication, field training module, HCP email series, access support set-up and 30/60/90-day metrics. Reuse it and record what changed for the next launch.

A repeatable launch cuts time to first prescriptions and avoids leftovers like "Available Soon" years later.

• Template ignored

  Make it part of stage-gate reviews.

• HiringDirector, Brand Marketing - CNS (Woburn, MA or Raleigh, NC; posted October 22, 2026): drive "North America brand strategy, in-line marketing execution, and launch planning for both current and future brand assets"; "Monitor brand performance, KPIs, and market dynamics"; oversee products "at various lifecycle stages (pre-launch, launch, growth, maturity)"; and work with sales training on "commercial training for the franchise".Source
• News coverageLamlique (lamotrigine) oral suspension was approved in late September 2026: a ready-to-use oral liquid that "does not require compounding or refrigeration", in 5 mg/mL and 25 mg/mL strengths, for epilepsy in patients 2 and older and bipolar I maintenance in adults, with a Boxed Warning for serious skin rashes.Source
• HiringManager, Sales Training (posted September 17, 2026): build "initial (new hire), launch, advanced and continuous training" across "multiple disease states", "Create scalable onboarding experiences that accelerate time-to-productivity", with "AI generated training content". Azurity is also hiring two Senior Managers, Global Medical Information (posted September 17, 2026).Source
• Brand websitezonisade.com, checked twice on October 23, 2026: the page title served to browsers and search engines reads "ZONISADE® (zonisamide oral suspension | Zonisamide Transformed | Now Approved - Available Soon!", and the site's structured data gives the description "Now Approved - Available Soon!". The meta description says ZONISADE is "the only FDA-approved oral liquid alternative to solid zonisamide doses". The site has "Provider Resources", "Request Information" and "Just For Pharmacists" sections.Source

For each hospital product, prepare a formulary dossier (labeled information, cost, storage and preparation details), a request form template and a medical information contact, available on request through the HCP support page. Track requests and decisions in CRM.

Formulary wins unlock every prescriber in a health system, and a ready kit shortens the process.

• Proactive dossier sharing rules

  Provide through medical information on request.

• HiringField expansion: Institutional Business Managers in at least nine territories (Central Valley, Columbus, Connecticut, Detroit, North Los Angeles, Phoenix South, Portland, Sacramento, South Atlanta), Hospital & Specialty Sales Representatives (San Jose, West Chicago) and a Regional Business Manager, Midwest, posted August to October 2026. Call points include "Hospital Pharmacy, OR, ICU"; preferred experience includes "Buy and Bill & Injectable product", oncology and "familiarity with P&T/Formulary process".Source
• HiringSenior CRM Business Analyst (posted September 10, 2026): "Our CX team at Azurity is building new capabilities utilizing cutting-edge AI and Engagement tools"; configures Salesforce Sales Cloud including "Territory Planning, Flow Automation, Events, Consent Management, Reporting, Dashboards, and CRM Analytics", with IQVIA and Snowflake data, under "HIPAA, GDPR, Sunshine Act, FDA guidance".Source
• Your websiteSitemap pages for healthcare professionals and partners: products A-Z, HCP support, patient access support, medical information, educational grant application, "partner with Azurity" and "Azurity's legacy companies"; the newsroom includes releases on Arbor, Covis, Slayback and Sebela deals and licensing deals with George Medicines and ACA Pharma.Source

After a logged call, send the HCP an approved follow-up with the materials discussed, if they have consented. Measure opens, samples and requests. Add AI-suggested next steps for reps, reviewed by a human.

Follow-ups extend each expensive visit at almost no cost and give marketing data on what interests prescribers.

• Consent errors

  Audit monthly.

• HiringSenior CRM Business Analyst (posted September 10, 2026): "Our CX team at Azurity is building new capabilities utilizing cutting-edge AI and Engagement tools"; configures Salesforce Sales Cloud including "Territory Planning, Flow Automation, Events, Consent Management, Reporting, Dashboards, and CRM Analytics", with IQVIA and Snowflake data, under "HIPAA, GDPR, Sunshine Act, FDA guidance".Source
• HiringOncology marketing build-out: a Head of Marketing (Sr. Director), US Oncology to lead "a small team of brand leads", the annual brand plan and "launch planning for pipeline assets", and manage "the topline revenue forecast while effectively managing gross to nets"; and a Senior Manager, US Marketing, Oncology (posted October 11, 2026) to run "omnichannel marketing campaigns" and "Engage with KOLs".Source
• HiringField expansion: Institutional Business Managers in at least nine territories (Central Valley, Columbus, Connecticut, Detroit, North Los Angeles, Phoenix South, Portland, Sacramento, South Atlanta), Hospital & Specialty Sales Representatives (San Jose, West Chicago) and a Regional Business Manager, Midwest, posted August to October 2026. Call points include "Hospital Pharmacy, OR, ICU"; preferred experience includes "Buy and Bill & Injectable product", oncology and "familiarity with P&T/Formulary process".Source

Publish approved standard responses by product with search on the medical information page, keep a request form for anything else, and track the top questions to feed training and labeling discussions.

Faster answers help prescribers and pharmacists choose and keep using a product.

• Off-label questions

  Route to individual responses only.

• HiringManager, Sales Training (posted September 17, 2026): build "initial (new hire), launch, advanced and continuous training" across "multiple disease states", "Create scalable onboarding experiences that accelerate time-to-productivity", with "AI generated training content". Azurity is also hiring two Senior Managers, Global Medical Information (posted September 17, 2026).Source
• Your websiteSitemap pages for healthcare professionals and partners: products A-Z, HCP support, patient access support, medical information, educational grant application, "partner with Azurity" and "Azurity's legacy companies"; the newsroom includes releases on Arbor, Covis, Slayback and Sebela deals and licensing deals with George Medicines and ACA Pharma.Source
• News coverageLamlique (lamotrigine) oral suspension was approved in late September 2026: a ready-to-use oral liquid that "does not require compounding or refrigeration", in 5 mg/mL and 25 mg/mL strengths, for epilepsy in patients 2 and older and bipolar I maintenance in adults, with a Boxed Warning for serious skin rashes.Source

Build role-play scenarios (hospital pharmacist, neurologist, oncology pharmacist) from approved materials, let new reps practise with AI and get scored on accuracy and compliance, and have managers review samples.

Practice before the first call improves message accuracy and confidence across a fast-growing team.

• AI says unapproved things

  Restrict to approved content and review transcripts.

• HiringManager, Sales Training (posted September 17, 2026): build "initial (new hire), launch, advanced and continuous training" across "multiple disease states", "Create scalable onboarding experiences that accelerate time-to-productivity", with "AI generated training content". Azurity is also hiring two Senior Managers, Global Medical Information (posted September 17, 2026).Source
• HiringField expansion: Institutional Business Managers in at least nine territories (Central Valley, Columbus, Connecticut, Detroit, North Los Angeles, Phoenix South, Portland, Sacramento, South Atlanta), Hospital & Specialty Sales Representatives (San Jose, West Chicago) and a Regional Business Manager, Midwest, posted August to October 2026. Call points include "Hospital Pharmacy, OR, ICU"; preferred experience includes "Buy and Bill & Injectable product", oncology and "familiarity with P&T/Formulary process".Source

Add approved titles, descriptions and preview images to both sites, link the awareness site to patient support resources, and build an omnichannel plan for oncology pharmacists and specialty pharmacies focused on labeled dosing and access.

The new team can start with sites that represent the brand properly in search and in KOL-shared links.

• Unbranded and branded mixing

  Keep the awareness site unbranded under its rules.

• News coverageDanziten (nilotinib tablets) was approved in November 2024 for Philadelphia chromosome-positive CML; its labeling has no requirement to fast around doses, unlike the original nilotinib product, and it carries a Boxed Warning for QT prolongation. Azurity also runs a CML awareness site, cmlunfinishedfight.com, whose served HTML holds only the title "CML Unfinished Fight".Source
• HiringOncology marketing build-out: a Head of Marketing (Sr. Director), US Oncology to lead "a small team of brand leads", the annual brand plan and "launch planning for pipeline assets", and manage "the topline revenue forecast while effectively managing gross to nets"; and a Senior Manager, US Marketing, Oncology (posted October 11, 2026) to run "omnichannel marketing campaigns" and "Engage with KOLs".Source
• Brand websitesThe HTML served by arynta.com, lamlique.com, eprontia.com and javadin.com has no page title, no meta description and no social preview tags; katerzia.com and danziten.com send only the brand name as the title. The pages fill in only after scripts run. zonisade.com, on WordPress, does send a full title and description.Source

Build a pharmacist program: wholesaler ordering details, a stocking alert for new launches, a continuing-education webinar on liquid formulations, and a direct line for questions. Promote through pharmacy trade media.

Pharmacists influence switches and stocking, and a ready-to-use product saves them compounding time.

• Promotional limits on CE

  Use an independent accredited provider.

• News coverageLamlique (lamotrigine) oral suspension was approved in late September 2026: a ready-to-use oral liquid that "does not require compounding or refrigeration", in 5 mg/mL and 25 mg/mL strengths, for epilepsy in patients 2 and older and bipolar I maintenance in adults, with a Boxed Warning for serious skin rashes.Source
• Brand websitezonisade.com, checked twice on October 23, 2026: the page title served to browsers and search engines reads "ZONISADE® (zonisamide oral suspension | Zonisamide Transformed | Now Approved - Available Soon!", and the site's structured data gives the description "Now Approved - Available Soon!". The meta description says ZONISADE is "the only FDA-approved oral liquid alternative to solid zonisamide doses". The site has "Provider Resources", "Request Information" and "Just For Pharmacists" sections.Source
• Competitor researchEton Pharmaceuticals' homepage: "an innovative pharmaceutical company that searches the world over for meaningful therapies that we can bring to patients living with rare diseases", with a product list of specialty and pediatric formulations. Azurity's ready-to-use liquids also compete with generic tablets and capsules of the same molecules and with pharmacy compounding.See the research Source

Score each product on prescription trend, brand and generic search demand, site visits and access status. Put digital budget on the top quartile, maintain the middle and plan phase-outs for the bottom.

Focus gives a large portfolio better returns from the same budget.

• Data gaps

  Use ranges and flag low-confidence scores.

• HiringDirector, Franchise Portfolio Management - CNS (posted September 22, 2026): manage "brand plans, pricing strategies, forecasts", "line extensions and phase-outs", "recommend product discontinuations when needed", and work with corporate development "to identify, evaluate, and integrate external assets".Source
• News coverageAzurity operates in more than 50 countries with a portfolio of more than 50 medicines across therapeutic areas and dosage forms (after the Covis acquisition); in March 2026 its owner QHP Capital closed a $1.1 billion continuation vehicle to fund organic growth, business development and licensing, and M&A.Source
• HiringSenior CRM Business Analyst (posted September 10, 2026): "Our CX team at Azurity is building new capabilities utilizing cutting-edge AI and Engagement tools"; configures Salesforce Sales Cloud including "Territory Planning, Flow Automation, Events, Consent Management, Reporting, Dashboards, and CRM Analytics", with IQVIA and Snowflake data, under "HIPAA, GDPR, Sunshine Act, FDA guidance".Source

Add the criteria Azurity looks for (dosage forms, areas, stage), a confidential intake form, a list of past partnerships and a named contact, plus a version for distributors outside the U.S.

Inbound deal flow is cheap, and clear criteria bring better-fitting assets.

• Low-quality submissions

  Screen with the criteria questions.

• News coverageAzurity operates in more than 50 countries with a portfolio of more than 50 medicines across therapeutic areas and dosage forms (after the Covis acquisition); in March 2026 its owner QHP Capital closed a $1.1 billion continuation vehicle to fund organic growth, business development and licensing, and M&A.Source
• Your websiteSitemap pages for healthcare professionals and partners: products A-Z, HCP support, patient access support, medical information, educational grant application, "partner with Azurity" and "Azurity's legacy companies"; the newsroom includes releases on Arbor, Covis, Slayback and Sebela deals and licensing deals with George Medicines and ACA Pharma.Source
• HiringDirector, Franchise Portfolio Management - CNS (posted September 22, 2026): manage "brand plans, pricing strategies, forecasts", "line extensions and phase-outs", "recommend product discontinuations when needed", and work with corporate development "to identify, evaluate, and integrate external assets".Source

Build one access hub: benefits check, copay support, prior authorization help and pharmacy finder for every brand, reachable from each brand site and by phone, with status updates by text.

Fewer abandoned prescriptions and one support brand that physicians' offices learn once.

• Brand-specific needs

  Keep brand pages inside one hub.

• Your websiteSitemap pages for healthcare professionals and partners: products A-Z, HCP support, patient access support, medical information, educational grant application, "partner with Azurity" and "Azurity's legacy companies"; the newsroom includes releases on Arbor, Covis, Slayback and Sebela deals and licensing deals with George Medicines and ACA Pharma.Source
• Brand websitezonisade.com, checked twice on October 23, 2026: the page title served to browsers and search engines reads "ZONISADE® (zonisamide oral suspension | Zonisamide Transformed | Now Approved - Available Soon!", and the site's structured data gives the description "Now Approved - Available Soon!". The meta description says ZONISADE is "the only FDA-approved oral liquid alternative to solid zonisamide doses". The site has "Provider Resources", "Request Information" and "Just For Pharmacists" sections.Source
• News coverageAzurity operates in more than 50 countries with a portfolio of more than 50 medicines across therapeutic areas and dosage forms (after the Covis acquisition); in March 2026 its owner QHP Capital closed a $1.1 billion continuation vehicle to fund organic growth, business development and licensing, and M&A.Source

Publish an unbranded resource on medicines and swallowing difficulty: when to ask about other forms, how to measure liquid doses, questions for the pharmacist. Promote through caregiver groups and keep it separate from brand promotion.

Caregivers who ask for a suitable form create demand that brand marketing cannot reach directly.

• Seen as disguised promotion

  Follow unbranded rules strictly.

• News coverageZonisade was approved in July 2022 and reached U.S. retail pharmacies from October 17, 2022, as adjunctive therapy for partial-onset seizures in adults and patients 16 and older; it was described as the first and only FDA-approved oral liquid formulation of zonisamide.Source
• News coverageLamlique (lamotrigine) oral suspension was approved in late September 2026: a ready-to-use oral liquid that "does not require compounding or refrigeration", in 5 mg/mL and 25 mg/mL strengths, for epilepsy in patients 2 and older and bipolar I maintenance in adults, with a Boxed Warning for serious skin rashes.Source
• News coverageArynta (lisdexamfetamine dimesylate) oral solution, the first approved oral solution of lisdexamfetamine, became available in the U.S. in April 2026 (earlier than the mid-2026 timing announced in February) for ADHD in patients 6 and older; Adalvo is a commercial partner.Source
• Competitor researchEton Pharmaceuticals' homepage: "an innovative pharmaceutical company that searches the world over for meaningful therapies that we can bring to patients living with rare diseases", with a product list of specialty and pediatric formulations. Azurity's ready-to-use liquids also compete with generic tablets and capsules of the same molecules and with pharmacy compounding.See the research Source

Set one standard for every site: served titles and descriptions, preview tags, analytics and consent, speed budget, prescribing-information links and a quarterly audit. Apply it to every new brand site at launch.

Consistent sites cost less to run and avoid repeat errors across a growing portfolio.

• Agency resistance

  Write it into contracts.

• Your websiteazurity.com runs on Salesforce Experience Cloud. The HTML the server sends for the homepage, the products A-Z page, the HCP support page and news releases (checked October 23, 2026) has the same title, "Welcome to LWC Communities!", with no meta description, no Open Graph or social preview tags and no page text; content appears only after scripts run. The sitemap lists 102 URLs: 43 pages, 37 news releases and 22 leadership profiles, all re-dated September 2026.Source
• Brand websitesThe HTML served by arynta.com, lamlique.com, eprontia.com and javadin.com has no page title, no meta description and no social preview tags; katerzia.com and danziten.com send only the brand name as the title. The pages fill in only after scripts run. zonisade.com, on WordPress, does send a full title and description.Source
• Brand websitezonisade.com, checked twice on October 23, 2026: the page title served to browsers and search engines reads "ZONISADE® (zonisamide oral suspension | Zonisamide Transformed | Now Approved - Available Soon!", and the site's structured data gives the description "Now Approved - Available Soon!". The meta description says ZONISADE is "the only FDA-approved oral liquid alternative to solid zonisamide doses". The site has "Provider Resources", "Request Information" and "Just For Pharmacists" sections.Source
• HiringSenior CRM Business Analyst (posted September 10, 2026): "Our CX team at Azurity is building new capabilities utilizing cutting-edge AI and Engagement tools"; configures Salesforce Sales Cloud including "Territory Planning, Flow Automation, Events, Consent Management, Reporting, Dashboards, and CRM Analytics", with IQVIA and Snowflake data, under "HIPAA, GDPR, Sunshine Act, FDA guidance".Source

Reduce blocking scripts, load fonts efficiently, and prerender public pages. Recheck field data monthly.

Small speed gains help both search and the first impression with partners.

• Tag removal breaks analytics

  Test in staging.

• Chrome UX ReportReal visitors to azurity.com: Largest Contentful Paint at the 75th percentile is 2.6 s, just over Google's 2.5 s "good" threshold; INP 83 ms and CLS 0.06 are good.Source
• Your websiteazurity.com runs on Salesforce Experience Cloud. The HTML the server sends for the homepage, the products A-Z page, the HCP support page and news releases (checked October 23, 2026) has the same title, "Welcome to LWC Communities!", with no meta description, no Open Graph or social preview tags and no page text; content appears only after scripts run. The sitemap lists 102 URLs: 43 pages, 37 news releases and 22 leadership profiles, all re-dated September 2026.Source

Track speaker programs and KOL webinars in Salesforce events, show reps upcoming programs by territory, and let them invite consented HCPs.

Peer education drives adoption in oncology, and attendance rises when local reps invite.

• Compliance rules for programs

  Follow speaker program policies.

• HiringOncology marketing build-out: a Head of Marketing (Sr. Director), US Oncology to lead "a small team of brand leads", the annual brand plan and "launch planning for pipeline assets", and manage "the topline revenue forecast while effectively managing gross to nets"; and a Senior Manager, US Marketing, Oncology (posted October 11, 2026) to run "omnichannel marketing campaigns" and "Engage with KOLs".Source
• HiringSenior CRM Business Analyst (posted September 10, 2026): "Our CX team at Azurity is building new capabilities utilizing cutting-edge AI and Engagement tools"; configures Salesforce Sales Cloud including "Territory Planning, Flow Automation, Events, Consent Management, Reporting, Dashboards, and CRM Analytics", with IQVIA and Snowflake data, under "HIPAA, GDPR, Sunshine Act, FDA guidance".Source
• HiringField expansion: Institutional Business Managers in at least nine territories (Central Valley, Columbus, Connecticut, Detroit, North Los Angeles, Phoenix South, Portland, Sacramento, South Atlanta), Hospital & Specialty Sales Representatives (San Jose, West Chicago) and a Regional Business Manager, Midwest, posted August to October 2026. Call points include "Hospital Pharmacy, OR, ICU"; preferred experience includes "Buy and Bill & Injectable product", oncology and "familiarity with P&T/Formulary process".Source

Track monthly search volume and ranking for brand, generic-name and "liquid/suspension" terms for each CNS product, and compare with prescriptions.

Search is an early signal of demand and of where content is missing.

• Search does not equal scripts

  Use as a leading indicator only.

• Competitor researchEton Pharmaceuticals' homepage: "an innovative pharmaceutical company that searches the world over for meaningful therapies that we can bring to patients living with rare diseases", with a product list of specialty and pediatric formulations. Azurity's ready-to-use liquids also compete with generic tablets and capsules of the same molecules and with pharmacy compounding.See the research Source
• News coverageLamlique (lamotrigine) oral suspension was approved in late September 2026: a ready-to-use oral liquid that "does not require compounding or refrigeration", in 5 mg/mL and 25 mg/mL strengths, for epilepsy in patients 2 and older and bipolar I maintenance in adults, with a Boxed Warning for serious skin rashes.Source
• News coverageZonisade was approved in July 2022 and reached U.S. retail pharmacies from October 17, 2022, as adjunctive therapy for partial-onset seizures in adults and patients 16 and older; it was described as the first and only FDA-approved oral liquid formulation of zonisamide.Source

Give partners a portal with approved global assets, product facts, training modules and a launch checklist, adapted per country by the partner with Azurity review.

Faster, consistent partner launches extend revenue from each approval.

• Local rules differ

  Partners adapt; Azurity reviews.

• News coverageAzurity operates in more than 50 countries with a portfolio of more than 50 medicines across therapeutic areas and dosage forms (after the Covis acquisition); in March 2026 its owner QHP Capital closed a $1.1 billion continuation vehicle to fund organic growth, business development and licensing, and M&A.Source
• Your websiteSitemap pages for healthcare professionals and partners: products A-Z, HCP support, patient access support, medical information, educational grant application, "partner with Azurity" and "Azurity's legacy companies"; the newsroom includes releases on Arbor, Covis, Slayback and Sebela deals and licensing deals with George Medicines and ACA Pharma.Source
• HiringManager, Sales Training (posted September 17, 2026): build "initial (new hire), launch, advanced and continuous training" across "multiple disease states", "Create scalable onboarding experiences that accelerate time-to-productivity", with "AI generated training content". Azurity is also hiring two Senior Managers, Global Medical Information (posted September 17, 2026).Source